Clinical case of long-term pemetrexed-based chemotherapy treatment for pulmonary adenocarcinoma (ALA +)

The article describes a clinical case of ALK-positive non-small cell lung cancer and its long-term treatment with a chemotherapy drug pemetrexed as first-line regimen followed by pemetrexed maintenance therapy.

Saved in:
Bibliographic Details
Published inMedical Council no. 19; pp. 68 - 72
Main Authors Lozhkina, A. M., Sviridenko, M. A., Cheremnykh, A. O., Filippova, E. A., Urtenova, M. A., Odintsova, S. V., Orlov, S. V.
Format Journal Article
LanguageEnglish
Russian
Published Remedium Group LLC 11.11.2018
Subjects
maintenance therapy
non-small cell lung cancer
pemetrexed
Online AccessGet full text

Cover

More Information
Summary:The article describes a clinical case of ALK-positive non-small cell lung cancer and its long-term treatment with a chemotherapy drug pemetrexed as first-line regimen followed by pemetrexed maintenance therapy.
ISSN:2079-701X
2658-5790
DOI:10.21518/2079-701X-2018-19-68-72